Global Leukapheresis Market, By Type (Leukapheresis Devices, Leukapheresis Disposables), Application (Research Applications, Therapeutic Applications), End User (Blood Component Providers and Blood Centers, Academic and Research Institutes, Pharmaceutical and Biotechnology Companies, Hospitals and Transfusion Centers), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) Industry Trends and Forecast to 2028
Leukapheresis market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market to account to USD 51.96 billion by 2028 and will grow at a CAGR of 8.16% in the above mentioned forecast period.
Leukapheresis is a process used for separating white blood cells from a sample of blood. It can be performed to decrease the count of very high white blood cell, to achieve cells for various research purposes and to attain autologous blood cells for further transplant back into patient.
The increasing incidence and prevalence of leukemia is amongst the important factors intensifying the growth and demand of leukapheresis market. In addition, the high demand for leukopaks in clinical research, growing number of blood donations, technological advancements as well as increasing demand and adoption of leukopaks in various applications such as R&D activities are also contributing to the growth in the global market over the forecast period of 2021 to 2028. Also the rising investments by major players for research activities, associated with increasing approvals for process of isolating white blood corpuscles (WBC) for R&D activities are also lifting the market growth in the above mentioned forecast period. The emerging economies and rising investments from pharma-biotech companies, academic institutes and leading players which will further accelerate the expansion of the leukapheresis market and are also are offering significant growth opportunities for the market in the forecast period of 2021 to 2028.
However, the high cost of therapeutic leukapheresis and leukopaks as well as lack of skilled professionals and low adoption of therapeutic leukapheresis will curb the growth of the leukapheresis market, whereas the high cost of cellular immunotherapies and blood transfusion safety in developing countries have the potential to challenge the growth of the leukapheresis market.
This leukapheresis market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on leukapheresis market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Leukapheresis Market Scope and Market Size
Leukapheresis market is segmented on the basis of type, application and end user. The growth amongst these segments will help you analyze meager growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- On the basis of type, the leukapheresis market is segmented into leukapheresis devices and leukapheresis disposables. Leukapheresis devices have further been segmented into apheresis devices, leukapheresis columns and cell separators and leukoreduction filters.
- Based on application, the leukapheresis market is segmented into research applications and therapeutic applications.
- The end user segment of leukapheresis market is segmented into blood component providers and blood centers, academic and research institutes, pharmaceutical and biotechnology companies and hospitals and transfusion centers.
Leukapheresis Market Country Level Analysis
Leukapheresis market is analyzed and market size insights and trends are provided by country, type, application and end user as referenced above.
The countries covered in the leukapheresis market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa(MEA), Brazil, Argentina and Rest of South America as part of South America.
North America region leads the leukapheresis market owing to the presence of well-established healthcare infrastructure, rising number of patients suffering from leukemia, easy reimbursement policies and strong presence of major key players within emerging countries within the region. Asia-Pacific is expected to expand at a significant growth rate over the forecast period of 2021 to 2028 because of the growing government expenditure on development of healthcare infrastructure within this particular region.
The country section of the leukapheresis market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
Leukapheresis market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for leukapheresis market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the leukapheresis market. The data is available for historic period 2011 to 2019.
Competitive Landscape and Leukapheresis Market Share Analysis
Leukapheresis market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to leukapheresis market.
The major players covered in the leukapheresis market report are Asahi Kasei Medical Co. Ltd, Haemonetics Corporation, TERUMO BCT INC., STEMCELL Technologies Inc., Fresenius SE & Co. KGaA, HemaCare, B. Braun Melsungen AG, Caltag Medsystems Limited, AllCells, StemExpress, PPA, Cellero, Precision for Medicine, Inc., Lonza, BioIVT, Lmb Technologie GmbH, Grifols, S.A, and Kaneka Pharma Europe NV among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
Customization Available : Global Leukapheresis Market
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.